A novel three-microRNA signature for predicting survival in patients with nasopharyngeal carcinoma
Open Access
- 8 September 2021
- journal article
- research article
- Published by Elsevier BV in Journal of Dental Sciences
- Vol. 17 (1), 377-388
- https://doi.org/10.1016/j.jds.2021.08.017
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- MicroRNAs in nasopharyngeal carcinomaChinese Clinical Oncology, 2016
- Sp1 transcription factor: A long-standing target in cancer chemotherapyPharmacology & Therapeutics, 2015
- MicroRNA-93 promotes cell growth and invasion in nasopharyngeal carcinoma by targeting disabled homolog-2Cancer Letters, 2015
- MicroRNA Therapeutics: the Next Magic Bullet?Mini-Reviews in Medicinal Chemistry, 2015
- miR-29a/b Enhances Cell Migration and Invasion in Nasopharyngeal Carcinoma Progression by Regulating SPARC and COL3A1 Gene ExpressionPLOS ONE, 2015
- TGFβR2 is a major target of miR-93 in nasopharyngeal carcinoma aggressivenessMolecular Cancer, 2014
- A four‐miRNA signature identified from genome‐wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinomaInternational Journal of Cancer, 2013
- MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinomaCancer Letters, 2013
- Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysisThe Lancet Oncology, 2012
- Molecular Diagnosis of Nasopharyngeal Carcinoma: Detecting LMP‐1 and EBNA by Nasopharyngeal SwabOtolaryngology -- Head and Neck Surgery, 2004